The estimated Net Worth of De Notaristefani Carlo is at least $15.8 Million dollars as of 14 June 2011. De Carlo owns over 221,455 units of Bristol-Myers Squibb Co stock worth over $15,501,813 and over the last 16 years De sold BMY stock worth over $264,500.
De has made over 11 trades of the Bristol-Myers Squibb Co stock since 2009, according to the Form 4 filled with the SEC. Most recently De exercised 221,455 units of BMY stock worth $6,147,591 on 14 June 2011.
The largest trade De's ever made was exercising 221,455 units of Bristol-Myers Squibb Co stock on 14 June 2011 worth over $6,147,591. On average, De trades about 20,619 units every 46 days since 2009. As of 14 June 2011 De still owns at least 319,033 units of Bristol-Myers Squibb Co stock.
You can see the complete history of De Carlo stock trades at the bottom of the page.
Over the last 16 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, and Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: